Last January the email remembered in its section El Correo 25 years ago the reading of the thesis of Bartolomé Burguera, a compostelano licensed at the Faculty of Medicine of the USC.That brilliant lesson had as a title regulation by glucocorticoids and strokes gives growth hormone secretion and was read before a court chaired by the Professor of Physiology at the University of Córdoba, Enrique Aguilar.
Now, a quarter of a century later, Bartolomé Burguera has become one of the most prestigious endrocrinologists and has become with his investigations a revolutionary of this specialty in the United States, where he has exercised for 25 years except after a nine -year interval ofin which he developed his studies in Palma de Mallorca.
This brilliant career, which is focused on morbid obesity and diabetes, is the one that has led to this compostela specialist already telling us as one of the members of the exclusive Galician club of the year.
Burguera was born in Santiago de Compostela and currently has 51 years, he is married, he has two children and resides in the American city of Cleveland, where he is director of the programs against obesity in the endocrinology and metabolism Institute Cleveland Clinic.
Currently its main scientific interest is the implementation of a program similar to the tramomtana, of interdisciplinary medical approach for morbid obese patients who are not candidates for bariatric surgery.Likewise and as a medical director of the Baiatric Institute (BMI), he collaborates with Dr. Schauer both to optimize the status of obese patients before undergoing bariatric surgery, and to develop alternative medical treatments to surgery and follow -up, in patients who do not respondto bariatric interventions.
CurriculumAfter concluding his medical studies at the USC and carrying out his doctoral thesis he had the opportunity to carry out a postdoc in the United States.Specifically, working with the expensive doctors and beings in North Carolina where the first studies were developed showing the beneficial effect of bariatric surgery as an important tool in the treatment of obesity and diabetes, in the 90s.
Subsequently, he made another postdoctoral period at the NIH before starting his clinical training in Norwalk Hospital (University of Yale) and at the Mayo Clinic.During his years as Fellow at the Mayo Clinic he had the opportunity to make significant contributions to the role of leptin in the regulation of appetite in humans.Subsequently, Dr. Burguera worked as an endocrinologist at Boston University, and in Pittsburgh where he directed the obesity clinic and began a fruitful scientific collaboration with the Bariatric surgeon Phil Schauer, evaluating both the impact of bariatric surgery on the resolution of the resolution of the resolution of the resolution of the resolution of theDiabetes, such as Ghrelin's role in appetite regulation after surgery.
In 2004 he moved to Spain where he directed the Research Unit of the Reference Hospital in Palma de Mallorca and launched two important clinical trials.
In the summer of 2013 he returned to the United States, after accepting the position of Director of Obesity Programs of the Institute of Endocrinology at Cleveland Clinic.
